Wird geladen...
Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature
INTRODUCTION: While serine-threonine kinases (STK) are attractive therapeutic targets in epithelial ovarian cancer, clinical outcomes of STK inhibitors in the management of recurrent disease have not been completely described. AREAS COVERED: A systematic literature review of published clinical studi...
Gespeichert in:
| Veröffentlicht in: | Expert Opin Investig Drugs |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534810/ https://ncbi.nlm.nih.gov/pubmed/27101098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2016.1181748 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|